In collaboration with CAE, the project’s primary goal is to identify an appropriate material to isolate a battery pack in a hybrid electric aircraft. The chosen material must be as light as possible, while meeting appropriate safety standards. This battery module will be integrated into an aircraft for testing by the industry partner. With a […]

In this project, the team will build a strong business foundation for a startup vehicle ‘Neuropeutics Inc’ to conduct further R&D and commercialize a new effective treatment for neurodegenerative diseases, namely ALS and FTD. That is, the team will develop a sustainable business model, a financial budget, a funds raising plan and marketing material. The […]

Surgery places significant stress on the body, much like running a marathon does. However, while marathon runners rigorously train before their race, most Canadians are not preparing for surgeries. Not only does a wealth of data exist supporting the notion of “better in, better out”, when it comes to surgery outcomes, but being in a […]

Canine leptospirosis is a climate-sensitive, bacterial, infectious disease of global importance. Despite being vaccine-preventable, leptospirosis is an important cause of morbidity and mortality in dogs. Across North America and the United Kingdom (UK), the prevalence of canine leptospirosis ranges between 4.8-14%, with evidence for increasing prevalence over time. Leptospirosis can be difficult or slow to […]

NorthMiRs is developing nanotechnology-enabled gene therapies for the treatment of sepsis. We have determined microRNAs that are dysregulated in septic patients and packaged them into a stable, synthetic, and scalable lipid nanoparticle delivery vehicle. Our lead therapeutic, NM-001, a miRNA replacement therapy for sepsis-associated cardiomyopathy has been shown to be anti-inflammatory, anti-microbial and protects organs […]

EPAID Technology: EPilepsy AI-Driven Technology aims to automate electrophysiological signal processing practice to assist clinicians in the treatment of epilepsy. We will partner with Springboard, who provides strategically positioned resources to Atlantic Canadian universities and colleges alike, helping them transfer both knowledge and technology into the private sector.

Myelofibrosis is a chronic and life-threatening blood disease. There is a need for accurate risk stratification approaches to guide personalized medicine decisions for these patients. To address this need, we developed a non-invasive blood-based test that is cost-effective, scalable and accurate. Through the Lab2Market program we will explore the market and develop the business case […]

The range of contemporary engineering careers extend far beyond those closely tied to the traditional disciplines taught in engineering schools. Using Canadian Census 2021 data, this study will examine the occupational outcomes of engineering graduates residing in Ontario, with specific attention to the differences between industry sectors of employment and along lines of race, gender, […]

Spero Analytics is an IoT startup which deploys wireless environmental monitoring systems for the waste management and oil and gas industries. The core of our technology is a proprietary mesh network which can transmit data from sensors without the need for cellular infrastructure, using little energy, and requiring minimal maintenance. This project will focus on […]

Heat illness is a spectrum of disorders due to environmental exposure to heat. There is a growing need to combat worker heat exposure in mines, as a function of increasing mine depth. Vale’s Thermal Management Program is designed to protect workers from the hazards of hot conditions, but in dynamic work environments, and among workers […]

“RemoteCare” is a novel initiative that empowers individuals to conduct part of their medical assessments independently via a user-friendly remote digital solution. By enabling self-assessments, it reduces physician workload, minimizes wait times, and ensures quicker access to medical assistance, especially in underserved areas. However, its progress hinges on gaining the trust of traditional healthcare providers, […]

1 in 13 men in Canada is diagnosed with colon cancer every year. And 1 in 29 will die consequently. 1 in 16 women in Canada are similarly diagnosed leading to death in 1 out of 34 women. More than 90% of colon cancer cases start as a small benign growth called polyp. These polyps […]